JP2024539458A - 破壊されたtdp-43結合部位を有するヒト化スタスミン2マウスモデルに関連する方法および組成物 - Google Patents
破壊されたtdp-43結合部位を有するヒト化スタスミン2マウスモデルに関連する方法および組成物 Download PDFInfo
- Publication number
- JP2024539458A JP2024539458A JP2024529784A JP2024529784A JP2024539458A JP 2024539458 A JP2024539458 A JP 2024539458A JP 2024529784 A JP2024529784 A JP 2024529784A JP 2024529784 A JP2024529784 A JP 2024529784A JP 2024539458 A JP2024539458 A JP 2024539458A
- Authority
- JP
- Japan
- Prior art keywords
- mouse
- stmn2
- sequence
- tdp
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Environmental Sciences (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Toxicology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163282023P | 2021-11-22 | 2021-11-22 | |
| US63/282,023 | 2021-11-22 | ||
| PCT/US2022/080224 WO2023092118A1 (en) | 2021-11-22 | 2022-11-21 | Methods and compositions relating to humanized stathmin2 mouse model with disrupted tdp-43 binding sites |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539458A true JP2024539458A (ja) | 2024-10-28 |
| JP2024539458A5 JP2024539458A5 (https=) | 2025-11-13 |
Family
ID=86397888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529784A Pending JP2024539458A (ja) | 2021-11-22 | 2022-11-21 | 破壊されたtdp-43結合部位を有するヒト化スタスミン2マウスモデルに関連する方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250040523A1 (https=) |
| EP (1) | EP4436586A4 (https=) |
| JP (1) | JP2024539458A (https=) |
| KR (1) | KR20240116486A (https=) |
| CN (1) | CN118284707A (https=) |
| IL (1) | IL312770A (https=) |
| WO (1) | WO2023092118A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120519523A (zh) * | 2025-05-21 | 2025-08-22 | 首都医科大学附属北京天坛医院 | 一种基于Sptlc-E260K点突变构建的ALS小鼠模型及其构建方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120192298A1 (en) * | 2009-07-24 | 2012-07-26 | Sigma Aldrich Co. Llc | Method for genome editing |
| AU2020466994A1 (en) * | 2019-09-17 | 2022-04-21 | Rutgers, The State University Of New Jersey | Highly efficient DNA base editors mediated by RNA-aptamer recruitment for targeted genome modification and uses thereof |
-
2022
- 2022-11-21 IL IL312770A patent/IL312770A/en unknown
- 2022-11-21 WO PCT/US2022/080224 patent/WO2023092118A1/en not_active Ceased
- 2022-11-21 CN CN202280077093.0A patent/CN118284707A/zh active Pending
- 2022-11-21 US US18/711,686 patent/US20250040523A1/en active Pending
- 2022-11-21 EP EP22896792.3A patent/EP4436586A4/en active Pending
- 2022-11-21 JP JP2024529784A patent/JP2024539458A/ja active Pending
- 2022-11-21 KR KR1020247020449A patent/KR20240116486A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL312770A (en) | 2024-07-01 |
| US20250040523A1 (en) | 2025-02-06 |
| EP4436586A4 (en) | 2025-10-08 |
| EP4436586A1 (en) | 2024-10-02 |
| WO2023092118A1 (en) | 2023-05-25 |
| KR20240116486A (ko) | 2024-07-29 |
| CN118284707A (zh) | 2024-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7101211B2 (ja) | ガイドrnaのペアを使用したターゲティングによる遺伝子改変の方法及び組成物 | |
| EP3392337A1 (en) | Genetic modification non-human organism, egg cells, fertilized eggs, and method for modifying target genes | |
| Kolli et al. | Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases | |
| Jones et al. | Modeling human epilepsy by TALEN targeting of mouse sodium channel Scn8a | |
| KR102670361B1 (ko) | 유전자 발현 조절을 위한 인위적인 게놈 조작 | |
| WO2016133165A1 (ja) | Cas9 mRNAを哺乳動物の受精卵にエレクトロポレーションにより導入する方法 | |
| JP6958917B2 (ja) | 遺伝子ノックイン細胞の作製方法 | |
| Hims et al. | A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect | |
| US20190359972A1 (en) | Compositions and Methods for Scarless Genome Editing | |
| US20250040523A1 (en) | Methods and compositions relating to humanized stathmin2 mouse model with disrupted tdp-43 binding sites | |
| Schmouth et al. | Modelling human regulatory variation in mouse: finding the function in genome-wide association studies and whole-genome sequencing | |
| US8476485B2 (en) | Non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 function | |
| Polikarpova et al. | Genetically modified animal models of hereditary diseases for testing of gene-directed therapy | |
| US20250340870A1 (en) | Systems, methods, and compositions for altering the expression of endogenous circular rnas | |
| US20250002944A1 (en) | Allele specific editing to treat fus-induced neurodegeneration | |
| WO2020050294A1 (ja) | 相同組換え効率上昇剤及びその使用 | |
| Ivanenko et al. | Genome Editing in Therapy of Genodermatoses | |
| US20230287459A1 (en) | Single generation targeted gene integration | |
| Anjomani Virmouni | Genotype and phenotype characterisation of Friedreich ataxia mouse models and cells | |
| EP4489567A2 (en) | Wild-derived mouse models of alzheimer's disease | |
| KR101634244B1 (ko) | Talen을 이용하여 grk5 넉아웃 마우스를 제조하는 방법 | |
| Gabig-Cimińska et al. | HUMAN GENETIC DISORDERS PART 2–DIAGNOSIS AND TREATMENT | |
| Malik | Development and analysis of CTG repeat expansion cell lines to understand molecular events in myotonic dystrophy type 1 | |
| HK40009103B (en) | Methods for targeted genetic modification using paired guide rnas | |
| HK1236222B (en) | Methods and compositions for targeted genetic modification using paired guide rnas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251105 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251105 |